Nuveen Asset Management, LLC Cti Biopharma Corp Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.2 - $6.01 $236,422 - $338,308	-56,291 Reduced 4.32%	1,247,261 $5.24 Million
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $222,308 - $308,234	-49,957 Reduced 3.69%	1,303,552 $7.83 Million
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $2.13 Million - $2.95 Million	-396,684 Reduced 22.67%	1,353,509 $7.88 Million
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $6.21 Million - $11 Million	1,750,193 New	1,750,193 $10.4 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.